Article

  • The EMBO Journal (2006) 25, 798 - 810
  • doi:10.1038/sj.emboj.7600977

Published online: 9 February 2006

A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity

Daniela Bosisio1,ab, Ivan Marazzi1,a, Alessandra Agresti2,a, Noriaki Shimizu3, Marco E Bianchi4 and Gioacchino Natoli5

  1. Institute for Research in Biomedicine, Bellinzona, Switzerland
  2. San Raffaele Scientific Institute, Milan, Italy
  3. Faculty of Integrated Arts and Sciences, Hiroshima University, Hiroshima, Japan
  4. San Raffaele University, Milan, Italy
  5. European Institute of Oncology, Milan, Italy

Correspondence to:

Marco E Bianchi, San Raffaele University, Via Olgettina 58, 20132, Milan, Italy. Tel.: +39 02 26434 763; Fax: +39 02 26434 861; E-mail: bianchi.marco@hsr.it

Gioacchino Natoli, Department of Experimental Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. Tel.: +39 02 5748 9953; Fax: +39 02 5748 9851; E-mail: gioacchino.natoli@ifom-ieo-campus.it

aThese authors contributed equally to this work

bPresent address: General Pathology and Immunology, University of Brescia, Viale Europa 11, Brescia, Italy

Received 26 July 2005; Accepted 19 December 2005


Because of its very high affinity for DNA, NF-kappaB is believed to make long-lasting contacts with cognate sites and to be essential for the nucleation of very stable enhanceosomes. However, the kinetic properties of NF-kappaB interaction with cognate sites in vivo are unknown. Here, we show that in living cells NF-kappaB is immobilized onto high-affinity binding sites only transiently, and that complete NF-kappaB turnover on active chromatin occurs in less than 30 s. Therefore, promoter-bound NF-kappaB is in dynamic equilibrium with nucleoplasmic dimers; promoter occupancy and transcriptional activity oscillate synchronously with nucleoplasmic NF-kappaB and independently of promoter occupancy by other sequence-specific transcription factors. These data indicate that changes in the nuclear concentration of NF-kappaB directly impact on promoter function and that promoters sample nucleoplasmic levels of NF-kappaB over a timescale of seconds, thus rapidly re-tuning their activity. We propose a revision of the enhanceosome concept in this dynamic framework.


  • Keywords:

    • enhanceosome,
    • kinetic microscopy,
    • NF-kappaB,
    • Rel,
    • transcription

Introduction

Top

After degradation of their cytoplasmic inhibitors (IkappaBs), the homo- and hetero-dimers composed of the five NF-kappaB/Rel proteins (p65/RelA, c-Rel, RelB, p50 and p52) (Thanos and Maniatis, 1995a; Verma et al, 1995; Ghosh et al, 1998) translocate to the nucleus and bind thousands of 9–10 nt kappaB sites dispersed in the genome (Martone et al, 2003; Natoli et al, 2005) in order to activate transcription of 200–300 genes implicated in inflammation, immune response and antiapoptosis. Mechanistic understanding of NF-kappaB-regulated transcription requires the definition of the kinetic properties of NF-kappaB interaction with this large number of sites.

In vitro results indicate that in comparison with most transcription factors (TFs) (whose affinity for cognate sites is generally close to 10-9 M), NF-kappaB dimers have a very high affinity for kappaB sites (from 10-13 to 10-10 M) (Urban and Baeuerle, 1990; Chen-Park et al, 2002), and generate very stable complexes with a half-life of 45 min (Zabel and Baeuerle, 1990). NF-kappaB–DNA complexes are further stabilized by cooperative protein–protein interactions with other sequence-specific TFs and architectural proteins, giving rise to multimolecular protein–DNA complexes called enhanceosomes. In vitro the interferon beta (IFN-beta) enhanceosome (Maniatis et al, 1998) remains completely stable for over 10 h (Yie et al, 1999), but the existence of stable transcription complexes containing NF-kappaB in vivo remains to be proven.

Here, we carried out an in vivo kinetic and quantitative analysis of NF-kappaB activation, recruitment to and persistence on target genes, and transcriptional induction. We found that NF-kappaB association with target sites contained within transcriptionally active genes results in its transient immobilization, that is, a measurable reduction in mobility as compared to the nucleoplasmic NF-kappaB molecules. Such transient immobilization generates a window of opportunity during which encounter with partner TFs and recruitment of the transcriptional machinery must occur for transcription to start. This window of opportunity is, however, very short: complete turnover of NF-kappaB on activated chromatin occurs in less than 30 s. The fast dynamics of NF-kappaB binding and unbinding generates a dynamic equilibrium between promoter-bound and nucleoplasmic NF-kappaB dimers: cyclic oscillations in the nucleoplasmic pool of NF-kappaB induce parallel oscillations in promoter occupancy and transcriptional activity, which are dissociated from the occupancy of the same promoter by other TFs.

Taken together, these data indicate that NF-kappaB and the TFs interacting with adjacent binding sites do not generate stable enhanceosomes, but rather undergo short and individual interactions with their respective binding sites. Thus, the enhanceosome can be considered a well-defined set of molecular species, but a hyperdynamic one: each molecular species is represented inside the enhanceosome by individual molecules that belong to it for a very short time.

Mobility of nucleoplasmic NF-kappaB

We first used fluorescence recovery after photobleaching (FRAP) to analyze the average mobility of nucleoplasmic GFP-tagged NF-kappaB dimers. The GFP tag did not affect the ability of p65 to bind endogenous genes and to activate their transcription, indicating that this fusion protein is fully functional (Supplementary Figure S1). Because the kinetic properties of a given protein are similar among several different cell types (Phair et al, 2004b), we chose HeLa cells for ease of transfection.

In tumor necrosis factor (TNF)-stimulated HeLa cells, p65-GFP showed very rapid recovery kinetics, even faster than that of GR (Figure 1A and B), which is known to turn over rapidly on its binding sites (McNally et al, 2000). The high nuclear mobility of p65 cannot be accounted for by overexpression, as p65-GFP represents only a fraction of endogenous p65 (on average, about 50%; data not shown); moreover, cells expressing low and high levels of fluorescence, and therefore with lower and higher levels of endogenous plus transfected p65, had similar FRAP recovery kinetics (data not shown).

Figure 1.

Figure 1 :

Evaluation of p65/RelA nuclear mobility in living cells. All curves were averaged from 15 cells each; bars represent standard error. (A) FRAP analysis of GFP-wt p65 and of a GFP fusion with a mutant p65 that does not bind kappaB sites. GFP-p65 is cytoplasmic in >95% of HeLa cells before TNF treatment (data not shown). FRAP analysis was started 20 min after TNF stimulation. The difference between the wt and mutant p65-GFP curves is statistically highly significant (P<0.0001). (B) FRAP analysis of GFP-GR (in cells treated with dexamethasone for 20') and of a nuclear GFP (NLS-GFP) (Bonaldi et al, 2003). (C) Quantitative analysis of FRAP in cells coexpressing p50 and GFP-wt p65 or GFP-mut p65. The difference between the two curves is significant (P<0.05) in the first 3 s.

View full figure (129 KB)

For comparison, we tested the mobility of a mutant p65-GFP with an about 1000-fold lower affinity for canonical kappaB sites (p65 23Y>A; 26 E>D) (Saccani et al, 2004; G Ghosh, personal communication). Mutant p65-GFP showed a FRAP recovery curve substantially faster than those of wild-type (wt) p65-GFP and of GFP-GR (Figure 1A and B) but much slower than that of GFP alone (Figure 1B), indicating that mutant p65 still interacts with chromatin.

We also performed similar FRAP experiments in HeLa cells cotransfected with p65-GFP and p50, and therefore expressing a p50/p65-GFP heterodimer. The results were similar to those obtained with the p65 homodimer: the wt p50/p65-GFP heterodimer has a fast recovery curve, and the heterodimer containing the mutated p65-GFP has an even faster one (Figure 1C).

These results are consistent with the idea that the measured kinetics of wt p65 is dominated by the binding to high-affinity sites, which may exceed 10–14 000 in mammalian genomes (Martone et al, 2003; discussed in Natoli et al, 2005).

Rapid p65/RelA exchange on cognate binding sites in vivo

To further prove the specific binding of GFP-tagged NF-kappaB species to high-affinity kappaB sites, we constructed an array of 384 canonical kappaB sites (Figure 2A) and stably transfected it into HeLa cells. In many cells belonging to several different clones, a bright spot of about 1.5 mum in diameter was evident after transfection with p50/p65-GFP; similar spots were never observed in control cells. A representative nucleus containing one such cluster, and three other clusters from different clones, are shown in Figure 2B. Clearly, a high concentration of kappaB sites produces a high local concentration of fluorescent p65-GFP molecules.

Figure 2.

Figure 2 :

NF-kappaB binding to high-affinity kappaB sites in living cells. (A) Schematic representation of the 384-kappaB construct, containing 128 repetitions of a basic unit of three tandem kappaB sites. (B) Visualization of an array of 384 kappaB sites in living cells. Cells bearing the 384-kappaB construct were cotransfected with p50 and GFP-p65, stimulated with TNF for 20 min, and viewed with a confocal microscope. Four representative nuclei (from different clones) are shown. (C) Selected FRAP images showing bleaching and recovery of one kappaB site array and a different area in the nucleus (encircled). (D) FRAP curves for p50/p65-GFP averaged from 15 nondescript areas in the nucleus ('nucleus') and eight 384 kappaB site arrays ('cluster'). Bars represent standard error. (E) FLIP analysis of NF-kappaB exchange on the kappaB site array. A representative nucleus is shown before and after the design of the bleach area (red). The image series shows the fluorescence loss from the array over time. FLIP curves (generated as described in Supplementary Figure S2) are averaged from seven 384 kappaB site arrays and 15 nondescript areas in the nucleus. Bars represent standard error. The difference between the two curves is statistically nonsignificant.

View full figure (314 KB)

We next measured FRAP recovery curves. Recovery on the arrays of kappaB sites was slower than on surrounding chromatin (Figure 2C and D), suggesting that NF-kappaB is immobilized onto high-affinity sites for longer than onto average genomic sequences, which contain kappaB sites with a wide range of affinities. Nonetheless, recovery was fast in absolute terms even on arrayed kappaB sites: In all, 50% recovery occurred in less than 1 s and 80% recovery was observed in about 5 s. Fluorescence on the 384 kappaB sites did not recover completely within 15 s, whereas fluorescence in other areas of the nucleus did. There are two most likely explanations for this behavior: a high probability of recapture of bleached NF-kappaB molecules dissociating from the tightly clustered kappaB sites, or the presence of an immobile fraction of NF-kappaB molecules.

To distinguish between these two possibilities, we used a modified fluorescence loss in photobleaching (FLIP) protocol. More than 90% of the nucleus (excluding the array or a control area) was repeatedly bleached (red area in Figure 2E), and fluorescence loss from the array (or the control area) into the bleached area was measured (Figure 2E). Fluorescent molecules on the array remain fluorescent if they do not move, whereas those leaving the array are bleached as soon as they enter the area targeted by the laser. In these conditions, even a minute amount of fluorescent molecules remaining stably bound to the cluster should stand out clearly. Differently from FRAP, which is affected by both the association and dissociation rates, our modified FLIP is intended to measure the dissociation rate of fluorescent molecules from the array. Some loss of fluorescence is due to photobleaching inherent in repeated imaging of the nucleus: we corrected for this effect as shown in Supplementary Figure S2. Even after correction, analysis of the curve and the errors (Supplementary Figure S3) indicated that less than 1% of NF-kappaB molecules remain on the cluster after 20 s.

These results indicate that the maximal residence time of NF-kappaB on high-affinity sites in vivo is less than 20 s; this residence time is not much different from that on average chromatin, suggesting once again that NF-kappaB mobility in average chromatin is dominated by interactions with high-affinity sites.

NF-kappaB turnover on transcriptionally functional promoters

The array of kappaB sites is artificial and, most important, not transcriptionally active. We then set out to measure the kinetics of NF-kappaB exchange at arrays of transcriptionally active NF-kappaB-dependent genes.

We constructed a basic unit consisting of the human immunodeficiency virus (HIV) 5' long terminal repeat (LTR), which contains two canonical kappaB sites, cloned upstream of a reporter gene encoding a cyan fluorescent protein (CFP) directed to peroxysomes via a C-terminal SKL tripeptide (Figure 3A). This NF-kappaB-responsive gene unit was cloned into the pSFV-dhfr vector. This plasmid contains both a mammalian replication initiation origin and a matrix attachment region from the Chinese hamster dhfr gene: when integrated into the genome, it initiates events similar to gene amplification in cancer cells, and it generates tandem repeats of up to 10 000 copies (Shimizu et al, 2001). We obtained arrays of several hundred plasmid copies in immortalized fibroblasts lacking both the p50 and p65 NF-kappaB subunits. Clone 2.24 was estimated by real-time polymerase chain reaction (PCR) to bear a repeat made of almost 2000 plasmid units (Supplementary Figure S4). After transfection of p65 and p50, TNF stimulation enhanced transcription of the CFP-SKL genes, as indicated by the increased CFP mRNA levels (Figure 3B), thus demonstrating that the array is transcriptionally active and NF-kappaB-regulated. Under the same conditions, HA-tagged p65 was efficiently recruited on the array, as shown by an anti-HA chromatin immunoprecipitation (ChIP) (Figure 3C). The HIV-CFP-SKL array was readily visualized upon TNF stimulation of cells reconstituted with untagged p50 and p65 tagged with monomeric red fluorescent protein (mRFP) (Figure 3D, left), although it was much less bright than the 384-kappaB site array (indicating a comparatively low density of kappaB sites). The morphology of the clusters varied from diffused (Figure 3D, top line) to beaded structures (bottom line), and was similar to the morphology of actively transcribed chromosome fibers and GR-responsive MMTV clusters (Muller et al, 2004).

Figure 3.

Figure 3 :

An array of transcriptionally functional NF-kappaB-regulated gene units. (A) Schematic representation of the NF-kappaB-regulated gene units amplified in clones 2.24 and 4.14. (B) NF-kappaB-dependent induction of CFP-SKL and luciferase mRNA. Clones 2.24 and 4.14 were transfected with p65 and left untreated (lanes '1') or stimulated with TNF-alpha for 1 h (lanes '2'). (C) Anti-HA-p65 ChIP on the HIV-LTR-CFP-SKL array. Clone 2.24 was transfected with HA-p65+p50 and stimulated with TNF-alpha for 15' or 30' as indicated. (D) Clones 2.24 and 4.14 were transfected with mRFP-p65 and GFP-rpbI; cells were stimulated with TNF for 30' and analyzed in vitro. Details of representative nuclei are shown, in which the arrays display a different morphology.

View full figure (172 KB)

In response to TNF stimulation, the HIV-CFP-SKL array recruited RNA-Pol II (GFP-RpbI) with a pattern that extensively overlapped the one generated by mRFP-p65 (Figure 3D, left), indicating that NF-kappaB recruitment coincides with productive transcription (or at least with the assembly of a preinitiation complex).

FRAP on the gene array showed 80% recovery in less than 3 s, and apparently complete recovery in about 30 s (Figure 4A). Recovery was anyway slower than that measured in the nucleoplasm, suggesting a transient immobilization of p65 on the array. The modified FLIP protocol described in the preceding section showed that the rate of NF-kappaB loss from the array was detectably smaller than the rate of loss from the control area (Figure 4B), demonstrating (in agreement with FRAP data) that NF-kappaB molecules spend a longer time on the cluster containing the HIV-1 LTR than in nondescript areas of the nucleus. However, all or nearly all NF-kappaB fluorescence was lost both from the array and the control area, suggesting that NF-kappaB molecules are not stably engaged with their sites. The experimental error does not allow us to formally and conclusively rule out the existence of an immobile fraction; however, similar to what we found for the array of kappaB sites (Supplementary Figure S3), if an immobile fraction exists it must be smaller than 2% (data not shown).

Figure 4.

Figure 4 :

Dynamics of NF-kappaB exchange on trascriptionally active chromatin. FRAP (A) and FLIP (B) curves on clone 2.24 (HIV-LTR) and 4.14 (synthetic gene). Curves are averaged from 10 clusters per type, and 20 nondescript areas in the nuclei (the two types of clones have been merged as there is no statistical difference between them). Bars represent standard error. The differences between the curves representing the two types of clusters are statistically nonsignificant, whereas the difference between any of the clusters and the rest of the nucleus is highly significant (P<0.001). In (B), the image series show the fluorescence loss over time at the cluster from one cell each of clones 2.24 and 4.14. FLIP curves are averaged from 10 cells each; bars represent standard error. The differences between the curves representing the two types of clusters are statistically nonsignificant, whereas the difference between any of the clusters and the rest of the nucleus is highly significant (P<0.002). (C) FRAP and (D) FLIP for S536A p65-GFP on the HIV-LTR cluster (clone 2.24). Curves are averaged from eight clusters and 10 nondescript areas in the nuclei; bars represent standard error.

View full figure (389 KB)

We also generated a second cell line (4.14) with an array of about 900 copies of a gene unit containing a synthetic NF-kappaB-regulated promoter (with three kappaB sites upstream of a minimal SV-40 promoter) driving the expression of a luciferase reporter (Figure 3A, B and D, right). Remarkably, results were indistinguishable from those obtained with the HIV-LTR (Figure 4A and B). Therefore, the kinetics of NF-kappaB exchange on transcriptionally active chromatin was similar in two completely unrelated gene arrays.

These results indicate that NF-kappaB interactions with target genes last a few seconds; as a consequence, the NF-kappaB-dependent events leading to transcriptional activation must take place on a similar timescale.

Active removal of NF-kappaB from chromatin

Such a fast exchange can be explained by at least two types of mechanisms. First, as NF-kappaB interaction with DNA is extremely salt-sensitive (Phelps et al, 2000), the exchange might occur spontaneously at the relatively high salt concentration in the cell (170 mM). The second possibility is that rapid exchange is active and catalyzed at least in part by nucleosome remodeling and proteasomal degradation, as demonstrated for GR recycling (Fletcher et al, 2002; Nagaich et al, 2004; Stavreva et al, 2004; Agresti et al, 2005). To directly address this point, we employed a p65 mutant (S536A) showing severely impaired signal-induced proteasomal degradation (Lawrence et al, 2005). FRAP recovery curves of S536A-p65-GFP clearly showed a large fraction of residual fluorescence on the clusters of HIV LTR even after 45 s; a similar result was obtained by FLIP (Figure 4C and D). These results demonstrate that NF-kappaB can reside for longer times on active genes, if its turnover is not catalyzed.

A dynamic equilibrium between promoter-bound and nucleoplasmic NF-kappaB

A prediction of the kinetic microscopy data is that NF-kappaB bound to target promoters should be in dynamic equilibrium with nucleoplasmic NF-kappaB molecules: if promoters are freely accessible, any change in nuclear abundance of NF-kappaB should cause an immediate and comparable change in target gene occupancy. To test this prediction, we used a quantitative ChIP assay to measure NF-kappaB recruitment to endogenous promoters in a cellular system in which NF-kappaB nuclear levels oscillate over time because of the rapid sequence of activation events (degradation of the IkappaBs and nuclear import) and negative feedback mechanisms (IkappaBalpha resynthesis) (Hoffmann et al, 2002).

In Raw264.7 murine macrophages, TNF-alpha and LPS induced different patterns of NF-kappaB oscillations (Figure 5A and B) that were detected by electrophoretic mobility shift assays (EMSA) carried out with a canonical kappaB site as a probe (5'-GGGACTTTCC-3'). TNF-alpha induced a rapid and short pulse of NF-kappaB activity, followed by two additional pulses (peaking at about 120' and 195'; Figure 5A, upper panel and data not shown). LPS-induced pulses were wider than those induced by TNF (Figure 5B, upper panel). Downregulation of NF-kappaB activity after the first pulse was less complete than with TNF-alpha; the second pulse of LPS-induced NF-kappaB activity was comparable in amplitude to the first one and was associated with a detectable simultaneous reduction in IkappaBalpha steady-state levels (Figure 5B).

Figure 5.

Figure 5 :

Pulses of NF-kappaB activity and recruitment of NF-kappaB to target genes. (A, B) Upper panels: EMSAs showing NF-kappaB activity in TNF-alpha- and LPS-stimulated Raw264.7 cells, respectively. A canonical kappaB site was used as a probe. Kinetics of IkappaBalpha degradation and resynthesis are shown. Lower panels: ChIP assays were carried out with an anti-p65 (red) or an anti-c-Rel (light blue) antibody, and recruitment to the IkappaBalpha or MIP-2 genes was measured by Q-PCR. Conventional ChIPs migrated on EtBr-stained gels are shown in small insets. Data are from a duplicate experiment and are representative of three independent experiments with similar results. (C) Re-ChIPs were carried out using the indicated antibodies on unstimulated and LPS-stimulated (15') Raw264.7 cell extracts. The chromatin immunoprecipitated in the first ChIP was divided into five aliquots and re-precipitated as indicated.

View full figure (232 KB)

NF-kappaB activity induced by both stimuli comprised the typical p50/p65 dimer and the p65/c-Rel heterodimer, which in many cell types is as abundant as p50/p65 (Hansen et al, 1994) and is best detected using the kappaB site from the human urokinase plasminogen activator (uPA) gene (5'-GGGAAAGTAC-3') (Supplementary Figure S5). The contribution of other complexes (e.g. p50/c-Rel, p52/c-Rel) to NF-kappaB activity was quantitatively small.

In response to TNF-alpha stimulation, p65/RelA and c-Rel occupancy of the IkappaBalpha and MIP-2 gene promoters (Figure 5A) closely resembled the profile of the bulk NF-kappaB activity as detected by EMSA: a high-amplitude cycle of NF-kappaB activity was followed by a second, low-amplitude cycle. In response to LPS stimulation, again both Rel proteins were detected onto DNA by ChIP in a manner that closely paralleled the cycles of NF-kappaB activity detected by EMSA (Figure 5B). Notably, the profiles of NF-kappaB activity induced by TNF-alpha and LPS were different; this indicates that the coincidence between total NF-kappaB activity and promoter occupancy is a causal relationship, and not a chance occurrence. Other promoters behaved identically to MIP-2 and IkappaBalpha (Supplementary Figure S6).

The identity of the NF-kappaB dimers recruited to chromatin in response to stimulation was further investigated by Re-ChIP experiments, in which the chromatin pulled-down in the first round of immunoprecipitation was re-precipitated with an antibody directed against a different NF-kappaB protein. Re-ChIPs showed that at a single time point multiple NF-kappaB dimers were promoter associated (Figure 5C). This indicates that each pulse of NF-kappaB activity detected by anti-p65 or anti-c-Rel ChIP in fact represents the sum of the signals generated by multiple p65- or c-Rel-containing dimers.

These results demonstrate that NF-kappaB-regulated promoters are occupied in proportion to the NF-kappaB-binding activity available at any one time, as predicted on the basis of the kinetic microscopy data.

Recruitment profile of partner TFs to NF-kappaB-dependent genes

A second prediction of the kinetic microscopy data is that NF-kappaB should not generate stable enhanceosomes composed of NF-kappaB and partner TFs bound to target promoters in a cooperative fashion. If stable enhancesomes existed, removal of NF-kappaB from target genes at the end of the first occupancy cycle detected by ChIP should be accompanied by the simultaneous removal of partner TFs (i.e. by the disassembly of the whole enhanceosome).

To address this issue, we analyzed recruitment of multiple TFs to the canonical, rapidly activated, NF-kappaB-dependent MIP-2 gene. The MIP-2 gene promoter contains an AP-1/CRE site adjacent to the distal kappaB site (Figure 6A) and a C/EBP site immediately downstream of the proximal kappaB site. In Raw 264.7 cells, LPS stimulation induced a sustained c-Jun amino-terminal phosphorylation and an increase in c-Jun levels, whereas TNF-alpha stimulation did not (Figure 6A). LPS induced a sustained occupancy of the MIP-2 promoter by c-Jun (Figure 6B). Remarkably, the c-Jun association profile with MIP-2 was completely different from that of p65/RelA and c-Rel; in particular, c-Jun did not show any cyclic behavior and was detected at the MIP-2 promoter between the two cycles of NF-kappaB recruitment (Figure 6B). We next analyzed the recruitment to the MIP-2 promoter of additional CRE/AP-1-binding proteins (Jun B and ATF-3) and of C/EBPbeta. MIP2 gene occupancy by JunB and ATF-3 (Figure 6D) paralleled the increase in their nuclear concentration induced by LPS stimulation (Figure 6C). Nuclear levels of C/EBPbeta did not change within this time frame (Figure 6C), but it was anyway efficiently recruited (Figure 6D). In all cases, these TFs displayed occupancy profiles different from those of NF-kappaB and could be detected at the promoter irrespective of NF-kappaB occupancy.

Figure 6.

Figure 6 :

Recruitment of partner TFs to the MIP-2 gene promoter is dissociated from NF-kappaB occupancy. (A) Relative position of the kappaB, CRE and C/EBP sites in the MIP-2 promoter. Immunoblots of LPS and TNF-stimulated cells were probed with antibodies to phospho-Ser63 c-Jun or total c-Jun. A Coomassie staining of the filter is also shown. (B) Anti-c-Jun ChIPs in LPS and TNF-stimulated Raw264.7 cells. An overlay of p65/RelA (red) and c-Jun (green) recruitment curves in cells stimulated with LPS is shown on the right. (C) Immunoblots of LPS-stimulated Raw264.7 cells were probed with antibodies to JunB, ATF-3 or C/EBPbeta. (D) Kinetics of JunB (left), ATF-3 (middle) and C/EBPbeta (right) recruitment to the MIP2 promoter in LPS-stimulated Raw264.7 cells were assayed by ChIP followed by real-time PCR. (E) Dynamics of histone H4 acetylation (black) and p65 recruitment profiles (red) at the MIP-2 (left) and IkappaBalpha (right) gene promoters in LPS-stimulated Raw264.7 cells. Acetylated and total H3 levels are also shown.

View full figure (247 KB)

Analysis of a slow-induced gene (Rantes/Ccl5) showed that p65 was recruited only during the second cycle of NF-kappaB nuclear accumulation, whereas c-Jun, JunB and C/EBPbeta occupied the promoter already at early time points (Supplementary Figure S7).

Therefore, NF-kappaB and partner TFs do not associate with, and are not released from target promoters as a single and stable complex.

Histone acetylation patterns at NF-kappaB-dependent genes are dynamical but not cyclical

NF-kappaB has been reported to interact with histone acetyltransferases and to mediate their recruitment to chromatin (Perkins et al, 1997; Zhong et al, 1998; Sheppard et al, 1999). Because estrogen receptor cycling on the pS2 gene promoter is associated with cyclical changes in histone H3 and H4 acetylation levels (Metivier et al, 2003), we asked whether the cycles of NF-kappaB recruitment we observed are paralleled by corresponding changes in histone acetylation.

Both MIP-2 and IkappaBalpha promoters are associated with relatively high basal levels of histone acetylation (Saccani et al, 2001). Quantitative ChIP showed a sharp peak of histone H4 and H3 hyperacetylation of MIP-2 promoter (about three-fold increase) at 15', followed by a rapid restoration of the initial acetylation levels that preceded NF-kappaB release (Figure 6E, left). The second phase of NF-kappaB recruitment was not associated with any detectable change in histone acetylation. At the IkappaBalpha gene promoter initial NF-kappaB recruitment was associated with a more than five-fold decrease in H3 and H4 acetylation (Figure 6E, middle); as total IkappaBalpha-associated H3 and H4 levels were not changed upon stimulation (Figure 6E, right and data not shown), the drop in acetylation detected by ChIP was mainly due to histone deacetylation, possibly mediated by recruitment of p65-associated histone deacetylases (Ashburner et al, 2001).

Overall, changes in histone acetylation at MIP-2 and IkappaBalpha gene promoters are dissociated from the cyclic changes in NF-kappaB occupancy.

Cyclic transcriptional activity at NF-kappaB-dependent genes

To determine how the recruitment profiles of NF-kappaB and partner TFs to target genes translate into changes in their transcriptional activity, we analyzed RNA Pol II recruitment using a ChIP assay with an antibody recognizing the RNA Pol II large subunit, rpbI. RNA Pol II association with the IkappaBalpha promoter increased in a cyclic fashion that closely matched the profile of p65/RelA and c-Rel occupancy (Figure 7A). Elongating RNA Pol II was also found to be present on an internal region (intron I) of the IkappaBalpha gene in a biphasic fashion (Figure 7A, right). The delay between maximal promoter occupancy by NF-kappaB and maximal RNA Pol II elongation in the second phase likely reflects the time needed by newly engaged RNA Pol II molecules to reach the intronic region detected by the probe. A similar cyclic RNA Pol II recruitment profile was detected at the MIP-2 gene (Figure 7B), thus indicating that each cycle of NF-kappaB occupancy of the target promoters is associated with active transcription, while TFs occupying the promoter between the two NF-kappaB pulses are not sufficient to prevent transcription shutdown. Although transcriptional activity is cyclic, steady-state MIP-2 and IkappaBalpha mRNA levels did not show parallel fluctuations and tended to accumulate during time (Figure 7C), indicating that the stability of these mRNAs buffers the effects of cyclic transcription. Finally, a similar correspondence between p65/RelA and RNA Pol II recruitment profiles was found at the IkappaBalpha and MIP-2 promoters in response to TNF-alpha stimulation (Figure 7D).

Figure 7.

Figure 7 :

Cycles of transcriptional activity parallel NF-kappaB recruitment pulses. (A) RNA Pol II recruitment to the IkappaBalpha gene promoter and intron 1 was assayed by anti-rpbI ChIP on extracts from LPS-stimulated Raw264.7 cells. p65 (red) and rpb1 (blue) recruitment curves on the IkappaBalpha promoter are overlaid (left). Please note y-axis scale differences. (B) RNA Pol II recruitment to the MIP-2 promoter. Curves were overlaid with p65 (red) and c-Jun (green) recruitment curves. (C) Quantitative mRNA analysis of IkappaBalpha and MIP-2 transcripts. (D) Kinetics of RNA Pol II recruitment (blue) to the IkappaBalpha and the MIP-2 promoters in TNF-stimulated cells, and overlay with the p65 recruitment curve (red).

View full figure (284 KB)

Discussion

Top

The transient nature of NF-kappaB:kappaB site interaction

Our kinetic microscopy analysis indicates that sequence-specific interactions of NF-kappaB with kappaB sites in vivo occur on a much faster timescale than expected from in vitro measurements. Three types of experiments with an increasing level of complexity and significance were carried out to analyze NF-kappaB mobility in the nucleus, on arrayed kappaB sites, and finally on transcriptionally active gene units.

FRAP experiments showed that the average nuclear mobility of p65/RelA was comparable or even faster than that of GR. This was further corroborated by the direct in vivo visualization of NF-kappaB exchange on kappaB sites contained within chromatinized, stably integrated arrays. Again, NF-kappaB was found to very rapidly exchange between the array and the rest of the nucleus. On active genes there was a transient but measurable immobilization of p65; nevertheless, the mobility was still very high and exchange complete or nearly complete.

Because active transcription and fast NF-kappaB exchange coexist, it can be concluded that preinitiation complex assembly and transcriptional activation do not require (and are not associated with) stable interactions of NF-kappaB with cognate sites. On the other hand, the transient immobilization of NF-kappaB on chromatin upon interaction with specific sites in active promoters likely represents a critical step in NF-kappaB-dependent gene induction: NF-kappaB residence time on specific sites defines a stochastic window during which general TFs (and possibly additional sequence specific TFs essential for activation) must collide with the same regulatory region for transcription to occur.

The removal of NF-kappaB from kappaB sites appears to be active and catalyzed, as a single-site mutation that impairs proteasomal degradation of p65 (Lawrence et al, 2005) can considerably extend its residence time on active genes.

A dynamic equilibrium between promoter-bound and nucleoplasmic NF-kappaB

The first implication of the rapid exchange of NF-kappaB between chromatin and the nucleoplasmic compartment is that maintenance of kappaB site occupancy will require the continuous supply of NF-kappaB dimers. Therefore, any oscillation in NF-kappaB nuclear levels will immediately reverberate on NF-kappaB occupancy of target genes, and any change in the abundance of different NF-kappaB dimers will cause a change in the relative representation of the NF-kappaB dimers bound to kappaB site-containing promoters ('dimer exchange', see Saccani et al, 2003). In other words, promoter-bound NF-kappaB is at equilibrium with its nucleoplasmic pool.

What is the relationship between the pulses of NF-kappaB recruitment to target genes detected by ChIP (i.e. pulses measurable on a timescale of tens of minutes) and the very fast exchange of NF-kappaB between target sites and nucleoplasm (i.e. an exchange measurable on a timescale of seconds)? And are the results obtained with the two techniques in conflict with each other?

If NF-kappaB:DNA complexes lasted tens of minutes, as suggested by the in vitro results (Zabel and Baeuerle, 1990), ChIP would detect a corresponding pulse of NF-kappaB association with target promoters, which is in fact the result we obtained. However, if the NF-kappaB:DNA complexes were short lasting, as suggested by the kinetic microscopy analysis, the results of the ChIP assay would be exactly the same. Indeed, formaldehyde handcuffs TFs on chromatin thus preserving labile and transient interactions and providing an average of the promoter occupancy status in the cell population at a given moment: a low degree of occupancy will be found when nuclear NF-kappaB levels are low and a high degree when nuclear levels are maximal, even if exchange in living cells (in the absence of formaldehyde) is very fast. In fact, ChIP does not provide any kinetic information on the duration of TF–DNA interactions, while kinetic microscopy does: when kinetics of NF-kappaB exchange (analyzed by FLIP or FRAP) and promoter occupancy (analyzed by ChIP) are assayed on the same chromatin target (HIV-CFP-SKL array in clone 2.24), it becomes obvious that a hyper-dynamic exchange underlies the apparently steady interaction of NF-kappaB with DNA revealed by ChIP.

Finally, the fact that multiple NF-kappaB dimers are simultaneously detected at target genes using Re-ChIP is consistent with the idea that all the dimers available in the nucleus at any given time point may transiently collide with the promoter with a frequency that mainly reflects their nuclear abundance (i.e. following probabilistic rules).

Revising the enhanceosome concept in a dynamic framework

The multiprotein complex of NF-kappaB, companion TFs and architectural proteins bound to the IFN-beta enhancer is the paradigm of enhanceosomes (Thanos and Maniatis, 1995b; Carey, 1998; Maniatis et al, 1998; Merika and Thanos, 2001). Other enhanceosomes containing NF-kappaB as an essential component have also been described (Whitley et al, 1994; Vanden Berghe et al, 1999). Enhanceosomes are supposed to be extremely stable (Yie et al, 1999), a concept that is obviously in contrast with the fast mobility of NF-kappaB on its cognate sites that we demonstrate here. Can we reconcile the apparently long-term existence of enhanceosomes with the short-term residence of NF-kappaB on DNA? We envision two possible scenarios. The first is simply that enhanceosomes form very fast and completely disassemble very fast, only to perform again a new, complete and fast assembly cycle. In this way, enhanceosomes would be present on average on enhancers, and thus may appear stable if assayed by ChIP in a population of cells, whereas they would appear extremely dynamic if individually analyzed. The second possibility is that enhanceosomes, as an assembly of multiple proteins species, are indeed stable; however, a given protein species in the enhanceosome would be in dynamic equilibrium with soluble molecules of the same species. In this interpretation, partially complete enhanceosomes would bind a specific molecule and become complete, only to lose another component molecule seconds later. Partially complete enhanceosomes would probably be the majority, but a formal demonstration of their existence may not be obtained by ChIP. Our data on the clusters of active genes do not allow us to formally exclude a third possibility, namely that a very small fraction of stable enhanceosomes exists that accounts for all transcriptional activity. However, we find this possibility very unlikely, given the substantial amount of RNA polymerase recruited to the clusters and its extensive colocalization with p65: both findings are difficult to reconcile with an extreme minority of active enhanceosomes.

The enhanceosome model also postulates that all TFs participate in enhanceosome assembly and thus are equally relevant: knock-down of any of them will result in loss of function (Thanos and Maniatis, 1995b). Conversely, our data indicate the existence of an obvious hierarchy, in which NF-kappaB dominates in promoting RNA Pol II recruitment and gene transcription. In fact, a drop in gene-bound RNA-Pol II accompanies any decay in NF-kappaB occupancy, thus suggesting that partner TFs (AP1, C/EBPbeta and others) may serve accessory roles not directly related to RNA-Pol II recruitment. Related to this point is the occupancy of the MIP-2 promoter by NF-kappaB and partner TFs. ChIP data indicate that AP-1 and C/EBP proteins have different occupancy profiles as compared to NF-kappaB, and that apparently they remain promoter-bound between the two cycles of NF-kappaB occupancy.

Overall, our data suggest that NF-kappaB and partner TFs associate with and dissociate from promoters quickly and largely independently from each other, and not as a single and highly stable complex. In fact, it is absolutely likely that all TFs are rapidly exchanging with chromatin on a timescale of seconds (Misteli, 2001; Phair et al, 2004a). In this light, any slow change (increase or decay) in promoter occupancy detected by ChIP (i.e. a change occurring on a timescale of minutes) can be interpreted as a direct consequence of a change in the equilibrium levels of each TF, whose rapid update relies on the fast association–dissociation cycles detected by kinetic microscopy.

A biological perspective

The transient immobilization of NF-kappaB on chromatin intuitively represents the best compromise between two essential and in part contrasting needs: the need to maximize the chances of a productive encounter with the transcriptional machinery; and the need to prevent the sequestration of NF-kappaB on the many thousand kappaB sites occurring in the genome. Moreover, rapid release from cognate sites grants that changes in the nuclear abundance of NF-kappaB dimers will be immediately 'sensed' by the target promoter, thus leading to a corresponding change in occupancy and transcriptional activity. In fact, the nuclear concentration of NF-kappaB will be sampled hundreds of times within a single NF-kappaB activation cycle, which allows promoters to quickly re-tune their activity as external conditions change. Such oversampling is possibly overkill for enabling the slow cycles observed under cell culture conditions, and an intriguing possibility is that rapid exchange may serve other purposes as well. However, real cells in real life might experience much more rapidly changing conditions that require mechanisms enabling a very fast adaptation. NF-kappaB-driven transcription occurs within minutes after stimulation and mediates a quick adaptation to a stressful situation, be it the encounter with a pathogen, the exposure to radiations or the release of inflammatory cytokines. As such, the transcriptional status of NF-kappaB-activated genes must be quickly re-tuned. To the contrary, the enhanceosome is supposed to be such a stable structure to be poorly responsive to environmental changes: once formed it reacts poorly (if at all) to changes in the external conditions that provoked its formation. Although the specific transcriptional needs of selected genes with very complex requirements (like the IFN-beta gene) (Maniatis et al, 1998) and/or sustained transcriptional activity (like the TCR alpha-chain gene) (Giese et al, 1995) may be best met by the assembly of stable enhanceosomes, our data strongly suggest that transcription of most NF-kappaB-dependent genes (that are rapidly and transiently induced) occurs via hyperdynamic interactions.

Materials and methods

Top

Antibodies

The following antibodies were obtained from Santa Cruz Biotechnology: anti-p65 sc-372; anti-c-Rel sc-71; anti-p52 sc-298; anti-c-Jun sc-1694; anti-JunB sc-8051; anti-ATF3 sc-188; anti-C/EBPbeta sc-150; anti rpbI sc-899. The anti-Ac-histone H3 (#06–599) and the anti-Ac H4 (#06–866) antisera were from Upstate Biotechnology Inc. The anti-H3 antibody (9712) and the anti-phospho Ser63 c-Jun antibody (9261) were from Cell Signaling Technology and the anti-p50 ab7971 from Abcam.

Electrophoretic mobility shift assay

EMSAs were performed as described (Saccani et al, 2001). The probes used were: kappaB 5'-AGTTGAGGGGACTTTCCCAGGC-3' and hum uPA kappaB 5'-GCTGCCTGCTGGGGAAAGTAC-3'.

Chromatin immunoprecipitation assays

ChIP assays were carried out as described (Saccani et al, 2001) with minor modifications (protocol is available upon request).

Wide-field imaging

Colocalization of GFP-pol II and mRFP-p65 was analyzed in living cells from clones 2.24 and 4.14 as described in Agresti et al (2005). The images (20 per cell) were spaced by 0.1 mum on the z-axis.

Confocal imaging

Stacks of images were acquired at 37°C on a Leica TCS SP2 AOBS confocal microscope with a times 63/1.4 NA oil immersion objective and times 6 zoom (512 times 512 pixels; voxel size 0.077 times 0.077 times 0.1 mum).

In vivo kinetic microscopy

HeLa cells were transfected with FuGene (Roche) with concentrations of GFP-p65/RelA expression vector optimized to achieve expression levels comparable to or lower than the endogenous protein. Cells were stimulated with TNF-alpha for 20 min before FRAP. FRAP was as described in Agresti et al (2005), except that zoom was times 6. Bleaching was performed on areas of radius 1 mum (Figure 1) or 0.75 mum (Figures 2 and 4).

FLIP experiments were performed with the same confocal microscope, with times 6 zoom at 470 ms per frame. Cells from clones 2.24 and 4.14 were transfected with p65-GFP and untagged p50 and stimulated for 20 min with TNF-alpha. Each experiment was repeated at least twice. Three 12-bit prebleaching frames were acquired with the 488 nm line at 10% of the maximal power. Repetitive bleaching was performed using FRAP settings on about 90% of the nucleus area, whereas simultaneously imaging the untargeted area (same settings as for prebleaching).

Array of kappaB sites

The kappaB-384 construct was generated using the strategy of Robinett et al (1996). The sequence of the basic unit containing three canonical kappaB sites (underlined) was: 5'-GATCCCTCGAGGGGACTTTCCGCTAGGGACTTTCCGCTAGGGACTTTCCG-3'. This unit was cloned in pUC19 by BamHI/SalI and sequentially doubled in seven identical cloning steps to reach 128 copies. The resultant kappaB-384 plasmid was cotransfected with pBabe-Puro in HeLa cells in a 20:1 ratio; single clones were picked after 12 days of selection with 1 mug/ml puromycin. Clones were screened for the presence of the array by PCR; positive clones were further screened by GFP-p65+p50 cotransfection and direct visualization of the array. Two clones (11 and 16) showing a single bright spot in most cells were selected for FRAP experiments.

Clones were transfected and stimulated as above. Stacks of 20 images centered on the bright fluorescent cluster of kappaB sites were acquired at 37°C with a times 60/1.4 NA oil immersion objective and times 6 zoom as described.

NF-kappaB-regulated gene arrays

The hygromycin resistance cassette in pSFV-dhfr (Shimizu et al, 2001) was excised by NruI–BamHI and replaced by a gene unit in which a 720 bp HindIII–XhoI fragment of the HIV1-LTR (from plasmid pHIV-CAT) (Nabel and Baltimore, 1987) drives the expression of a CFP variant bearing a C-terminal SKL tripeptide. The resulting plasmid, SFV-dhfr-HIV-LTR(CFP-SKL) was transfected into immortalized p65-p50 double knock-out mouse fibroblasts (a gift from K Marcu, SUNY at Stony Brook) and stable clones bearing amplified plasmid sequences were obtained by blasticidin selection (Shimizu et al, 2001, 2003). Clones were analyzed by Q-PCR using primers amplifying both the Chinese hamster DHFR genomic region contained in pSFV-dhfr and the endogenous mouse counterpart (Oribeta For: 5'-GCCTTAACCTTTGTTCTGTAAATG-3'; ORIbeta Back: 5'-GAGGCCATCTRTGRAGCTGCTG-3'). Copy number was estimated by comparing the Ct of the parental cells with those of individual clones. Stable clones bearing an amplified kappaB-luc gene unit were obtained by cotransfection of equimolar amounts of p3X-kappaB-luc and a pSFV-dhfr derivative (pDeltaBN-AR1) that efficiently promotes amplification of cotransfected plasmids (Shimizu et al, 2003).

The plasmid expressing a GFP-tagged rpb1 subunit of RNA Pol II was a kind gift of M Vigneron and K Sugaya (Sugaya et al, 2000). The mRFP-p65 vector was obtained by replacing the GFP coding sequence of hup65-GFP (Saccani et al, 2004) with the HindIII–BamHI fragment of pRSET-mRFP1 (Campbell et al, 2002). pRK-p65 S536A was a kind gift of T Lawrence and M Karin: the fragment containing the mutated amino acid was PCR amplified and used to replace the corresponding sequence in p65-GFP.

Statistical analysis

Statistical analysis was performed with the Prism 4 (GraphPad) using two-way analysis of variance.



Acknowledgements

Top

We thank G Verde (San Raffaele Scientific Institute) for unpublished results, and GM Wahl (Salk Institute, La Jolla), M Vigneron (INSERM, Strasbourg, France), K Sugaya (NIRS, Chiba, Japan), K Marcu (SUNY at Stony Brook), T Lawrence and M Karin for gifts of reagents. pHIV-CAT (from Dr G Nabel and Dr N Perkins) was obtained through the AIDS Research and Reference Reagent Program, NIAID, NIH. This work was supported by grants from the Swiss National Science Foundation and Oncosuisse to GN and from Ministero dell'Istruzione, Università e Ricerca to AA and MEB. DB was supported by a Roche Research Foundation fellowship. Author contributions. DB: experimental design and execution of the ChIP assays; IM: EMSAs and generation of the array constructs and cell lines; AA: design, execution and analysis of all the FRAP and FLIP experiments; NS: help with the generation of transcribed arrays; MB: FRAP and FLIP design and analysis and paper writing; GN: experimental design, generation of transcribed arrays, and paper writing.

References

Top

Agresti A, Scaffidi P, Riva A, Caiolfa VR, Bianchi ME (2005) GR and HMGB1 interact only within chromatin and influence each other's residence time. Mol Cell 18: 109–121 | Article | PubMed | ISI | ChemPort |

Ashburner BP, Westerheide SD, Baldwin Jr AS (2001) The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21: 7065–7077 | Article | PubMed | ISI | ChemPort |

Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME (2003) Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22: 5551–5560 | Article | PubMed | ISI | ChemPort |

Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, Zacharias DA, Tsien RY (2002) A monomeric red fluorescent protein. Proc Natl Acad Sci USA 99: 7877–7882 | Article | PubMed | ChemPort |

Carey M (1998) The enhanceosome and transcriptional synergy. Cell 92: 5–8 | Article | PubMed | ISI | ChemPort |

Chen-Park FE, Huang DB, Noro B, Thanos D, Ghosh G (2002) The kappa B DNA sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription. J Biol Chem 277: 24701–24708 | Article | PubMed | ISI | ChemPort |

Fletcher TM, Xiao N, Mautino G, Baumann CT, Wolford R, Warren BS, Hager GL (2002) ATP-dependent mobilization of the glucocorticoid receptor during chromatin remodeling. Mol Cell Biol 22: 3255–3263 | Article | PubMed | ISI | ChemPort |

Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225–260 | Article | PubMed | ISI | ChemPort |

Giese K, Kingsley C, Kirshner JR, Grosschedl R (1995) Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA binding and multiple protein–protein interactions. Genes Dev 9: 995–1008 | Article | PubMed | ISI | ChemPort |

Hansen SK, Baeuerle PA, Blasi F (1994) Purification, reconstitution, and IkappaB association of the c-Rel-p65 (RelA) complex, a strong activator of transcription. Mol Cell Biol 14: 2593–2603 | PubMed | ISI | ChemPort |

Hoffmann A, Levchenko A, Scott ML, Baltimore D (2002) The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298: 1241–1245 | Article | PubMed | ISI | ChemPort |

Lawrence T, Bebien M, Liu GY, Nizet V, Karin M (2005) IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434: 1138–1143 | Article | PubMed | ISI | ChemPort |

Maniatis T, Falvo JV, Kim TH, Kim TK, Lin CH, Parekh BS, Wathelet MG (1998) Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol 63: 609–620 | Article | PubMed | ISI | ChemPort |

Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, Luscombe NM, Rinn JL, Nelson FK, Miller P, Gerstein M, Weissman S, Snyder M (2003) Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci USA 100: 12247–12252 | Article | PubMed | ChemPort |

McNally JG, Muller WG, Walker D, Wolford R, Hager GL (2000) The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287: 1262–1265 | Article | PubMed | ISI | ChemPort |

Merika M, Thanos D (2001) Enhanceosomes. Curr Opin Genet Dev 11: 205–208 | Article | PubMed | ISI | ChemPort |

Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751–763 | Article | PubMed | ISI | ChemPort |

Misteli T (2001) Protein dynamics: implications for nuclear architecture and gene expression. Science 291: 843–847 | Article | PubMed | ISI | ChemPort |

Muller WG, Rieder D, Kreth G, Cremer C, Trajanoski Z, McNally JG (2004) Generic features of tertiary chromatin structure as detected in natural chromosomes. Mol Cell Biol 24: 9359–9370 | Article | PubMed | ISI | ChemPort |

Nabel G, Baltimore D (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711–713 | Article | PubMed | ISI | ChemPort |

Nagaich AK, Walker DA, Wolford R, Hager GL (2004) Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol Cell 14: 163–174 | Article | PubMed | ISI | ChemPort |

Natoli G, Saccani S, Bosisio D, Marazzi I (2005) Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6: 439–445 | Article | PubMed | ISI | ChemPort |

Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ (1997) Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275: 523–527 | Article | PubMed | ISI | ChemPort |

Phair RD, Gorski SA, Misteli T (2004a) Measurement of dynamic protein binding to chromatin in vivo, using photobleaching microscopy. Methods Enzymol 375: 393–414 | PubMed | ISI | ChemPort |

Phair RD, Scaffidi P, Elbi C, Vecerova J, Dey A, Ozato K, Brown DT, Hager GL, Bustin M, Misteli T (2004b) Global nature of dynamic protein–chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins. Mol Cell Biol 24: 6393–6402 | Article | PubMed | ISI | ChemPort |

Phelps CB, Sengchanthalangsy LL, Malek S, Ghosh G (2000) Mechanism of kappaB DNA binding by Rel/NF-kappaB dimers. J Biol Chem 275: 24392–24399 | Article | PubMed | ISI | ChemPort |

Robinett CC, Straight A, Li G, Willhelm C, Sudlow G, Murray A, Belmont AS (1996) In vivo localization of DNA sequences and visualization of large-scale chromatin organization using lac operator/repressor recognition. J Cell Biol 135: 1685–1700 | Article | PubMed | ISI | ChemPort |

Saccani S, Marazzi I, Beg AA, Natoli G (2004) Degradation of promoter-bound p65/RelA Is essential for the prompt termination of the NF-kappaB response. J Exp Med 200: 107–113 | Article | PubMed | ISI | ChemPort |

Saccani S, Pantano S, Natoli G (2001) Two waves of NF-kappaB recruitment to target promoters. J Exp Med 193: 1351–1359 | Article | PubMed | ISI | ChemPort |

Saccani S, Pantano S, Natoli G (2003) Modulation of NF-kappaB activity by exchange of dimers. Mol Cell 11: 1563–1574 | Article | PubMed | ISI | ChemPort |

Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, Collins T (1999) Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 19: 6367–6378 | PubMed | ISI | ChemPort |

Shimizu N, Hashizume T, Shingaki K, Kawamoto JK (2003) Amplification of plasmids containing a mammalian replication initiation region is mediated by controllable conflict between replication and transcription. Cancer Res 63: 5281–5290 | PubMed | ISI | ChemPort |

Shimizu N, Miura Y, Sakamoto Y, Tsutsui K (2001) Plasmids with a mammalian replication origin and a matrix attachment region initiate the event similar to gene amplification. Cancer Res 61: 6987–6990 | PubMed | ISI | ChemPort |

Stavreva DA, Muller WG, Hager GL, Smith CL, McNally JG (2004) Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Mol Cell Biol 24: 2682–2697 | Article | PubMed | ISI | ChemPort |

Sugaya K, Vigneron M, Cook PR (2000) Mammalian cell lines expressing functional RNA polymerase II tagged with the green fluorescent protein. J Cell Sci 113 (Part 15): 2679–2683

Thanos D, Maniatis T (1995a) NF-kappaB: a lesson in family values. Cell 80: 529–532 | Article | PubMed | ISI | ChemPort |

Thanos D, Maniatis T (1995b) Virus induction of human IFNbeta gene expression requires the assembly of an enhanceosome. Cell 83: 1091–1100 | Article | PubMed | ISI | ChemPort |

Urban MB, Baeuerle PA (1990) The 65-kD subunit of NF-kappaB is a receptor for IkappaB and a modulator of DNA-binding specificity. Genes Dev 4: 1975–1984 | PubMed | ISI | ChemPort |

Vanden Berghe W, De Bosscher K, Boone E, Plaisance S, Haegeman G (1999) The nuclear factor-kappaB engages CBP/p300 andhistone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem 274: 32091–32098 | Article | PubMed | ISI | ChemPort |

Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S (1995) Rel/NF-kappaB/IkappaB family: intimate tales of association and dissociation. Genes Dev 9: 2723–2735 | Article | PubMed | ISI | ChemPort |

Whitley MZ, Thanos D, Read MA, Maniatis T, Collins T (1994) A striking similarity in the organization of the E-selectin and beta-interferon gene promoters. Mol Cell Biol 14: 6464–6475 | PubMed | ISI | ChemPort |

Yie J, Merika M, Munshi N, Chen G, Thanos D (1999) The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. EMBO J 18: 3074–3089 | Article | PubMed | ISI | ChemPort |

Zabel U, Baeuerle PA (1990) Purified human IkappaB can rapidly dissociate the complex of the NF-kappaB transcription factor with its cognate DNA. Cell 61: 255–265 | Article | PubMed | ISI | ChemPort |

Zhong H, Voll RE, Ghosh S (1998) Phosphorylation of NF-kappaB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1: 661–671 | Article | PubMed | ISI | ChemPort |

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Shigella rewrites host transcriptional responses

Nature Immunology News and Views (01 Jan 2007)